Literature DB >> 27071453

Prostate cancer: ROR-γ drives androgen receptor expression.

Louise Stone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27071453     DOI: 10.1038/nrurol.2016.71

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.

Authors:  Junjian Wang; June X Zou; Xiaoqian Xue; Demin Cai; Yan Zhang; Zhijian Duan; Qiuping Xiang; Joy C Yang; Maggie C Louie; Alexander D Borowsky; Allen C Gao; Christopher P Evans; Kit S Lam; Jianzhen Xu; Hsing-Jien Kung; Ronald M Evans; Yong Xu; Hong-Wu Chen
Journal:  Nat Med       Date:  2016-03-28       Impact factor: 53.440

  1 in total
  2 in total

Review 1.  Circadian rhythms and cancers: the intrinsic links and therapeutic potentials.

Authors:  Li Zhou; Zhe Zhang; Edouard Nice; Canhua Huang; Wei Zhang; Yong Tang
Journal:  J Hematol Oncol       Date:  2022-03-04       Impact factor: 17.388

2.  A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma.

Authors:  Jin Liu; Zhao Tan; Shijie Yang; Xinda Song; Wenping Li
Journal:  Aging (Albany NY)       Date:  2022-09-13       Impact factor: 5.955

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.